Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Core One Labs
(OTCQB:CLABF)
Intraday
$0.19
0.0324
[20.56%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$0.19
0.0324
[20.56%]
Last update: 9:26AM
Get Real Time Here
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Core One Labs Stock (OTC:CLABF)
Core One Labs Stock (OTC: CLABF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, July 24, 2023
Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More
Lara Goldstein
-
Jul 24, 2023, 5:14PM
Core One Labs Enters Into LOI For First Sale Of Its Psychedelic Compounds
Vuk Zdinjak
-
Jul 24, 2023, 9:51AM
Monday, May 08, 2023
Core One In Talks With Multiple Companies To Supply Psilocybin
Vuk Zdinjak
-
May 8, 2023, 10:37AM
Monday, April 24, 2023
Core One's Awakened Lays The Groundwork For The Large-Scale Production Of Psychedelic Compounds With Synthetic Production Of Psilocin
Vuk Zdinjak
-
Apr 24, 2023, 10:26AM
Thursday, January 26, 2023
Across The Globe: Psychedelic Trials To Treat Late-Stage Cancer, Alzheimer's Begin
Lara Goldstein
-
Jan 26, 2023, 1:30PM
Wednesday, January 25, 2023
Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More
Lara Goldstein
-
Jan 25, 2023, 12:02PM
Saturday, January 21, 2023
Here Are The Latest Psychedelics Partnerships From Production & Supply Chain To Community Action
Lara Goldstein
-
Jan 21, 2023, 5:47PM
Wednesday, December 28, 2022
Psyched: Canada's Psychedelic Therapy Guidelines, $39M Series B For Next-Gen Drugs, Mexico's Ancestral Roots & More
Lara Goldstein
-
Dec 28, 2022, 8:47AM
Wednesday, December 21, 2022
Psychedelic Mushrooms Soon To Be Commercially Produced And Sold In Canada
Lara Goldstein
-
Dec 21, 2022, 8:35AM
Monday, September 26, 2022
Psychedelics Developer & Mass-Scale Manufacturer Will Deliver Novel Magic Mushroom Products
Lara Goldstein
-
Sep 26, 2022, 3:41PM
Friday, September 02, 2022
New Biosynthetic Psilocybin Hits The Psychedelics Market, Available For Research And Clinical Trials
Lara Goldstein
-
Sep 2, 2022, 1:26PM
Wednesday, April 06, 2022
Core One Labs Begins Trading On OTCQB
Fermin Orgambide
-
Apr 6, 2022, 2:15PM
Monday, December 27, 2021
Psychedelics Company Core One Labs Dives Into Functional Mushrooms With New $3M Acquisition
Natan Ponieman
-
Dec 27, 2021, 1:02PM
Monday, October 18, 2021
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
Natan Ponieman
-
Oct 18, 2021, 1:37PM
Wednesday, October 13, 2021
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Natan Ponieman
-
Oct 13, 2021, 4:25PM
Monday, August 23, 2021
Psyched: Beckley Psytech Raises $80M, Diamond Therapeutics To Study Psilocybin Microdosing, Mydecine and Johns Hopkins Partner Up
Natan Ponieman
-
Aug 23, 2021, 9:01AM
Monday, May 10, 2021
Psyched: Groundbreaking Phase 3 Results On MDMA, Small Pharma, Wesana Go Public, Gilgamesh Raises $27M
Natan Ponieman
-
May 10, 2021, 10:49AM
Monday, May 03, 2021
Stocks to Buy for the "Summer of New York"
Gregory Bergman - CapitalWatch
-
May 3, 2021, 12:58PM
Monday, April 26, 2021
Psyched: MindMed and Atai Head For Nasdaq, Psychedelics Search Platforms Grow, Champignon Brands Gets Back To Trading
Natan Ponieman
-
Apr 26, 2021, 7:58AM
Monday, April 12, 2021
Psyched: Entheon Launches Psychedelics Genetic Test, Mydecine Unveils Psychedelic Drug Candidates, California Bill Passes Senate Committee
Natan Ponieman
-
Apr 12, 2021, 8:12AM
Tuesday, April 06, 2021
Psyched: MindMed's 2020 Financials, Psychedelics ETF Rebalancing, Country's First Psychedelics Masters Degree
Natan Ponieman
-
Apr 6, 2021, 11:39AM
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week
The Cannabis Investor
-
Apr 6, 2021, 9:17AM
Friday, January 01, 2021
Psyched: The First Psychedelics ETF, Beckley Raises $19M, 3 Companies Go Public
Natan Ponieman
-
Jan 1, 2021, 10:49AM
Friday, January 03, 2020
The Week In Cannabis: Illinois Goes Rec, Quebec Pulls Back And A Recap Of 2019
Javier Hasse
-
Jan 3, 2020, 4:30PM
Core One Labs Subsidiary Completes Harvests Of Top Grade Flower At Adelanto Indoor Grow
Nina Zdinjak
-
Jan 3, 2020, 12:02PM
Monday, December 09, 2019
Core One Labs Subsidiary Enters Into Project With Reiziger Holland To Boost Harvest Yields
Nina Zdinjak
-
Dec 9, 2019, 12:02PM
Sunday, December 08, 2019
The Week In Cannabis: Brazil Regulates Sales, Michigan Starts Adult Sales, Lil Wayne Goes Green, Federal Agencies Move Forward
Javier Hasse
-
Dec 8, 2019, 12:50PM
Thursday, December 05, 2019
Core One Labs Posts Q3 Net Loss, Signs LOI For Cultivation Contract With Golden State Banana
Nina Zdinjak
-
Dec 5, 2019, 11:42AM
Monday, November 04, 2019
Stocks That Hit 52-Week Lows On Monday
Lisa Levin
-
Nov 4, 2019, 2:45PM
Friday, October 18, 2019
Stocks That Hit 52-Week Lows On Friday
Lisa Levin
-
Oct 18, 2019, 10:36AM
Wednesday, October 09, 2019
Stocks That Hit 52-Week Lows On Wednesday
Lisa Levin
-
Oct 9, 2019, 12:55PM
